Published on: 4 December 2024

The Research and Development team George Eliot Hospital NHS Trust are celebrating reaching major recruitment milestones as part of their involvement in the WHiTE PLATFORM trials.

IMG_1295.JPEGThe WHiTE Platform framework is being ran by the Oxford Trauma & Emergency Care research group, embedded in the Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences at the University of Oxford.

The WHiTE LIT trial explores whether patients aged 60 and over who suffer a hip fracture will benefit from an infusion of a local anaesthetic (lidocaine) in reducing symptoms of delirium in the first five days after hip fracture surgery.

Similarly, the WHiTE PRESSURE trial looks to see if the risk of pressure ulcers for hip fracture patients is reduced through the early use of heel off-loading devices and constant low-pressure devices. This has the potential to improve rehabilitation, recovery, and independence.

Overall, the George Eliot Hospital Trust has successfully recruited 76 (WHiTE LIT – 26 and WHiTE PRESSURE – 50) participants to the WHiTE PLATFORM trials.

Speaking on the achievement, Mr. Kishore Dasari, Orthopaedic and Trauma Consultant, and Dr. Suresh Krishnamoorthy, Cardiology Consultant, agreed that: “This contribution will hugely impact the current and future research and care we can offer our patients and help to improve clinical outcomes.

“The success of the recruitment to these trials is a testament to the dedication and hard work of every member of the research team, from clinical trial coordinators, research nurses, data managers, and clinical speciality teams.

“We would like to extend our heartfelt thanks to everyone involved for their contributions, which are making a real difference in the lives of our patients.

“We are proud of the entire research team who not only ensure the success of these trials but also demonstrate the strength of our collaboration and the impact it has on patient outcomes.

“We are thrilled with the progress we’ve made together and look forward to taking on more research projects that will continue to benefit our patients.”

The team are now looking to build on their initial success and will continue recruiting patients for all trials, building on the momentum created to potentially benefit more patients.

The team is confident that with continued dedication, they can further expand their research impact and contribute to even more meaningful advancements in healthcare.

If you would like to find more information about research at George Eliot Hospital NHS Trust and get involved visit www.geh.nhs.uk/research.